New Search

If you are not happy with the results below please do another search

1 search result for:

1

Tecentriq was approved in the US for the treatment of breast cancer

Roche’s immunotherapy drug Tecentriq was approved in the United States for treatment of patients suffering from triple negative breast cancer (TNBC), which is a progress in fight with this aggressive disease. The FDA approved Tecentriq in combination with a chemotherapeutic drug Abraxane for the treatment of inoperable locally advanced or metastatic TNMP in patients with…